ABCL Latest Headlines

AbCellera Biologics Announces Oversubscribed $200 Million Offering

at www.tipranks.com (Thu, 13-Aug 5:21 PM)

AbCellera Biologics prices oversubscribed $200M offering at $9.75/share

at seekingalpha.com (Thu, 13-Aug 1:14 AM)

AbCellera’s Strong Phase 2 Data Spotlight New Highs and Next Steps for ABCL635

Market Chameleon (Wed, 12-Aug 7:07 AM)

At a glance: stocks gapping down premarket

at seekingalpha.com (Wed, 12-Aug 7:16 AM)

ABCL Phase 2 Results Spark Renewed Interest: 83% Reduction in Vasomotor Symptoms Stands Out

Market Chameleon (Tue, 11-Aug 11:21 AM)

AbCellera launches $200 million share offering

at seekingalpha.com (Tue, 11-Aug 4:20 PM)

AbCellera Price Target Raised to $15 on Best-in-Class ABCL635 Phase 2 Data and Strategic Pipeline Momentum

at www.tipranks.com (Tue, 11-Aug 8:15 AM)

ABCL635 Delivers Statistically Significant Phase 2 Results—50% Greater Reduction in Hot Flashes Over Placebo

Market Chameleon (Mon, 10-Aug 10:31 AM)

ABCL635’s Phase 2 Results Show 83% Mean Reduction in Hot Flashes—A Potential Shift for Menopausal Symptom Relief

Market Chameleon (Mon, 10-Aug 7:06 AM)

AbCellera surges on positive mid-stage results for menopause drug ABCL635

at seekingalpha.com (Mon, 10-Aug 10:39 AM)

Analysts Offer Insights on Healthcare Companies: Novo Nordisk (NVO), Vanda (VNDA) and AbCellera Biologics (ABCL)

at www.tipranks.com (Mon, 10-Aug 8:40 AM)

At a glance: stocks gapping up premarket

at seekingalpha.com (Mon, 10-Aug 7:36 AM)

AbCellera Bolsters Liquidity With $100M in New Collaborations Despite Higher Q2 2026 Losses

Market Chameleon (Thu, 6-Aug 7:18 AM)

AbCellera Secures $28 Million Vertex Deal to Advance T-Cell Engager Platform for Autoimmune Therapies

Market Chameleon (Wed, 29-Jul 7:37 AM)

AbCellera Sets Q2 2026 Earnings Date—Clinical-Stage Pipeline Remains in Focus

Market Chameleon (Wed, 8-Jul 7:06 AM)

For Life Sciences AI, Data Is the New Moat: MindWalk’s Patent Filing Spotlights Industry Shift

Market Chameleon (Wed, 1-Jul 9:22 AM)

AbCellera Secures $56 Million Jazz Pharmaceuticals Deal to Develop Next-Gen T-Cell Antibody Therapies

Market Chameleon (Wed, 17-Jun 7:29 AM)